Here are the latest quarterly results of Dr. Reddys. For more details, see the Dr. Reddys financial fact sheet and Dr. Reddys share price and chart. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-19* |
3
Jun-19* |
3
Sep-19* |
3
Dec-19* |
3
Mar-20* |
3
Jun-20* |
3
Sep-20* |
3
Dec-20* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 40,296 | 38,582 | 48,128 | 43,971 | 44,489 | 44,265 | 49,109 | 49,419 | |
Other income | Rs m | 833 | 4,301 | 540 | 673 | 736 | 871 | 512 | 705 | |
Turnover | Rs m | 41,129 | 42,883 | 48,668 | 44,644 | 45,225 | 45,136 | 49,621 | 50,124 | |
Expenses | Rs m | 32,107 | 31,165 | 37,490 | 46,858 | 34,997 | 33,052 | 37,548 | 44,026 | |
Gross profit | Rs m | 8,189 | 7,417 | 10,638 | -2,887 | 9,492 | 11,213 | 11,561 | 5,393 | |
Depreciation | Rs m | 2,872 | 2,890 | 3,131 | 2,869 | 2,741 | 2,923 | 3,165 | 3,112 | |
Interest | Rs m | 245 | 298 | 303 | 152 | 230 | 233 | 252 | 188 | |
Profit before tax | Rs m | 5,905 | 8,530 | 7,744 | -5,235 | 7,257 | 8,928 | 8,656 | 2,798 | |
Tax | Rs m | 1,508 | 1,928 | -3,207 | 325 | -449 | 3,059 | 1,011 | 2,670 | |
Profit after tax | Rs m | 4,397 | 6,602 | 10,951 | -5,560 | 7,706 | 5,869 | 7,645 | 128 | |
Gross profit margin | % | 20.3 | 19.2 | 22.1 | -6.6 | 21.3 | 25.3 | 23.5 | 10.9 | |
Effective tax rate | % | 25.5 | 22.6 | -41.4 | -6.2 | -6.2 | 34.3 | 11.7 | 95.4 | |
Net profit margin | % | 10.9 | 17.1 | 22.8 | -12.6 | 17.3 | 13.3 | 15.6 | 0.3 | |
Diluted EPS | Rs | 26.5 | 39.8 | 66.1 | -33.6 | 46.5 | 35.4 | 46.1 | 0.8 | |
Diluted EPS (TTM) | Rs | 115.5 | 126.6 | 162.1 | 98.9 | 118.9 | 114.5 | 94.5 | 128.8 | |
![]() |
Read: Dr. Reddys 3QFY19 Result Performance Review
More Pharmaceuticals Company Quarterly Results: WYETH TTK HEALTHCARE PANACEA BIOTECH ALKEM LABORATORIES TORRENT PHARMA
Compare DR. REDDYS LAB With: WYETH TTK HEALTHCARE PANACEA BIOTECH ALKEM LABORATORIES TORRENT PHARMA
Compare DR. REDDYS LAB With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US) TEVA PHARMA (Israel)
Asian stock markets opened sharply lower today after Wall Street's main indexes tumbled, with technology-related stocks under pressure following a steep rise in benchmark US Treasury yields.
In this video, I'll cover your queries on intraday trading and also share my view on how to decide stop losses and target prices.
Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
A look at what India's top equity mutual funds bought and sold in January 2021.
Do you enjoy reading Tesla and Bitcoin stories? Here's a not so famous small-cap stock to profit from the rise of EVs.
More